Showing results (31-40 of 128) with videos related to

Sort By:
Pageof 13
Brain Research|October 13, 2004
The adenosine kinase inhibitor ABT-702 augments EEG slow waves in ratsRichard J Radek, Michael W Decker, Michael F Jarvis
Advances in Therapy|June 27, 2017
Gluten and Aluminum Content in Synthroid<sup>®</sup> (Levothyroxine Sodium Tablets)Ramon Espaillat, Michael F Jarvis, Cory Torkelson, et al.
Current Protocols in Pharmacology|June 12, 2012
High throughput functional assays for P2X receptorsMarian T Namovic, Michael F Jarvis, Diana Donnelly-Roberts
Purinergic Signalling|June 24, 2008
Selective P2X(7) receptor antagonists for chronic inflammation and painWilliam A Carroll, Diana Donnelly-Roberts, Michael F Jarvis
Current Topics in Medicinal Chemistry|January 11, 2005
Anticonvulsant and antinociceptive actions of novel adenosine kinase inhibitorsSteve McGaraughty, Marlon Cowart, Michael F Jarvis, et al.
Chembiochem : a European Journal of Chemical Biology|January 10, 2018
Design of Aminobenzothiazole Inhibitors of Rho Kinases 1 and 2 by Using Protein Kinase A as a Structure SurrogateRussell A Judge, Anil Vasudevan, Victoria E Scott, et al.
Current Pharmaceutical Biotechnology|April 7, 2011
Fibromyalgia: mechanisms, current treatment and animal modelsJill-Desiree Brederson, Michael F Jarvis, Prisca Honore, et al.
Journal of Neurophysiology|September 16, 2005
Systemic and site-specific effects of A-425619, a selective TRPV1 receptor antagonist, on wide dynamic range neurons in CFA-treated and uninjured ratsSteve McGaraughty, Katharine L Chu, Connie R Faltynek, et al.
Brain Research|February 20, 2003
Distinct neurochemical mechanisms are activated following administration of different P2X receptor agonists into the hindpaw of a ratCarol T Wismer, Connie R Faltynek, Michael F Jarvis, et al.
Pageof 13